Introduction {#S0001}
============

Type 2 diabetes mellitus (T2DM), a complex metabolic disease, is characterized by persistent hyperglycemia, insulin resistance and β-cell dysfunction.[@CIT0001] T2DM is not terrible; however, the chronic diabetes may cause complications in numerous organs and tissues throughout the body by affecting both small and large blood vessels.[@CIT0002] These have brought serious influences and burdens to people's life around the world.

Although there are numerous new kinds of anti-diabetic drugs, metformin still is the most widely used clinically as its obvious hypoglycemic effect and broad physiological roles. It is all known that metformin' history is linked to Galega officinalis, a traditional herbal medicine in Europe.[@CIT0003] And nowadays, mining chemical molecules with biological effects on natural plants has become an expanding field, especially for complicatedly non-communicable diseases. Traditional Chinese medicine (TCM) has a history of thousands years and still serves for hundreds of millions people around the world. *Carthamus tinctorius L*. (safflower) ([Figure 1A](#F0001){ref-type="fig"}) is one of the commonly used Chinese herbs, which is widely applied in the treatment of cardiovascular, cerebrovascular and gynecological diseases in China.[@CIT0004] As early as 2012, researchers[@CIT0005] had confirmed that the extract of Carthamus tinctorius L. could play an anti-diabetic role in alloxan-induced diabetic rats. However, there are more than 104 compounds have been isolated from *Carthamus tinctorius L*.[@CIT0006] which active ingredient in *Carthamus tinctorius L*. plays an anti-diabetic effect remains unknown.Figure 1Experimental drug and experimental scheme. (**A**) The picture of *Carthamus tinctorius L*. (*Safflower*). (**B**) The chemical structure (C27H32O16) of *hydroxysafflor yellow A* (HSYA). (**C**) Design of the animal experiment, including modeling method, time points and duration. The Nor group rats fed with standard laboratory diet, the other groups fed with high fat diet (HFD) in the whole course of the experiment. After 7days of adaptive phase, except for the Nor group rats, all rats were fed with HFD for 4 weeks, and followed by Intraperitoneal streptozotocin (STZ, 35 mg/kg). After 6 weeks of T2DM-modeling, the T2DM rats were divided into three groups for different interventions for 8 weeks.**Abbreviations:** Nor, Normal group; Mod, Model group; HSYA, hydroxysafflor yellow A; STZ, Streptozocin.

Hydroxysafflor yellow A (HSYA), a water-soluble monomer, can be extracted from *Carthamus tinctorius L*. (molecular formula, C~27~H~32~O~16~; Molecular Weight, 612.5 g/mol),[@CIT0007] depicted in [Figure 1B](#F0001){ref-type="fig"}. HSYA is one of the chemical components with biological effects in *Carthamus tinctorius L*., which is also widely applied in clinical practice in patients with cardiovascular and cerebrovascular diseases in China with its effects of oxygen-free radical scavenging, anti-inflammatory, and anti-apoptotic activities.[@CIT0008]--[@CIT0010] Moreover, the HSYA content is used for the standard of controlling quality of *Carthamus tinctorius L*. in authoritative Chinese Pharmacopoeia (The State Pharmacopoeia Commission of China, 2015). The oxidative stress, apoptotic and inflammation are hugely contributed to T2DM. Taken these, HSYA might be a main bioactive substance with hypoglycemic effect in *Carthamus tinctorius L*., which would be a potential anti-diabetic drug.

However, there is still no study of HSYA for the treatment of T2DM. HSYA could protect against cerebral ischemia-reperfusion injury by anti-apoptotic effect through increasing the expression of phosphorylations of Akt and GSK3b.[@CIT0011] Meanwhile, HSYA could protect neuronal-specific cells by activating the AKT-autophagy pathway in penumbra tissue.[@CIT0012] Therefore, we hypothesized that HSYA exerted an anti-diabetic effect by regulating the PI3K/AKT pathway and inhibiting apoptosis of pancreatic β-cells to improve insulin resistance and regulate the blood-glucose homeostasis.

The aim of our study was to explore the anti-diabetic effect of HSYA and its potential mechanism in T2DM rats. The T2DM rats were induced by the synthetic approach,[@CIT0013]--[@CIT0016] high-fat diet (HFD) for four weeks and followed by single injections with low-dose streptozotocin (30--40 mg/kg intraperitoneally); which has similar pathological features to human type 2 diabetes as eliciting partial loss of β-cells, and results in hypoinsulinemia and hyperglycaemia. In our study, T2DM rats were induced by feeding HFD (60% fat) for four weeks followed by intraperitoneal injection a low dose of streptozocin (35mg/kg). The T2DM rats were treated with HSYA or metformin for eight weeks.

Materials and Methods {#S0002}
=====================

Drugs {#S0002-S2001}
-----

STZ was obtained from Sigma (Sigma Chemical Co., St. USA). HSYA was purchased from Nanjing Daosf Biotechnology Co., Ltd. (CAS 78281-02-4, purity≥98%, HPLC, Nanjing city, China). Metformin was provided from Shiguibao (Shiguibao Co., Lt, Shanghai city, China).

Animal Experiment {#S0002-S2002}
-----------------

Male Wistar rats (weighted, 130±20g) were purchased from the Experimental Animal Center of Southern Medical University (Guangzhou city, China). All rats were kept in the Specific Pathogen Free (SPF) animal laboratory with free access to food and water. After seven days of adaptive feeding, they were fed with the HFD diet (60% fat) (the formula of HFD was shown in [[Supplementary Table 1](https://www.dovepress.com/get_supplementary_file.php?f=246381.doc)]{.ul}); and the other eight rats were fed with the standard diet, which set as the normal control group (Nor).

Four weeks after HFD feeding, they were intraperitoneally injected with a low dose of STZ (35mg/kg). Two weeks later, rats with the fasting-blood glucose (FBG) level of ≧11.1 mmol/L were randomly divided into three groups: T2DM model group (Mod, n=8), HSYA treatment group (HSYA, n=8) and metformin treatment group (Met, n=8). The detailed animal experiment design is shown in [Figure 1C](#F0001){ref-type="fig"}. After modeling, the T2DM rats were daily oral administrated with HSYA (120mg/kg) or metformin (90mg/kg) or normal saline for eight weeks. The dose of metformin is based on the daily dose conversion in humans (1.0g/d). After eight-week intervention, all animals were anaesthetized by sodium pentobarbital and blood sample was obtained from aorta abdominalis. Liver and pancreatic tissues were dissected, some of them were stored at −80°C immediately and the others were soaked in 10% neutral-buffered formalin for histomorphology experiment.

All animal procedures were conducted with protocol approval from the Bioethics Commission of Tsinghua University, according to the National Institute of Health ethical guidelines, and all efforts were made to minimize animal suffering.

Biochemical Analysis {#S0002-S2003}
--------------------

All rats' body weight, the food consumption (kcal/g) and water consumption (mL) were monitored weekly. The fasting-blood glucose (FBG) level was tested weekly from the tail vein by the glucometer (Roche Diagnostic Products Co. Ltd, Shanghai city, China). After eight-week treatment, the Oral-glucose-tolerance test (OGTT) was performed in 12 hours-fasted rats after oral administrated with glucose solution (2 g/kg, Sigma Aldrich, USA) at the time point of 0, 30, 60 and 120 minutes. The area under the curves (AUC) of OGTT was calculated according to the OGTT results.

The fasting blood insulin (FINS), triglycerides (TG), total serum cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) in serum were determined by test assay kits abide by the manufacturer's instructions (Beijing Solarbio Science & Technology Co., Ltd. Beijing city, China; Wuhan Mershack Biotechnology Co. Ltd. Wuhan city, China). The glycogen synthase (GS) was determined by WST-8 method. The hepatic glycogen in liver was detected by anthrone method according to the manufacturer's directions (Solarbio Science & Technology Co., Ltd. Beijing city, China). Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and homeostasis model assessment of β-cell function (HOMA-β) were calculated by the following formulas:[@CIT0017] HOMA-IR=FINS (mU/L)×FBG (mmol/L)/22.5, HOMA-β=(20×FINS mU/mL)/(FBG mmol/L--3.5).

Pancreatic Histology Analysis {#S0002-S2004}
-----------------------------

The pancreatic tissues which dissect from the animals were immersed in 10% neutral-buffered formalin for 48 hours. After fixation, they were prepared into paraffin sections of 4 µm, and stained with hematoxylin-eosin, and then observed on a fluorescence microscope. The fresh paraffin sections of pancreatic tissues were used for Immunohistochemical staining with the specific antibodies directed against insulin (Cat YT2357, ImmunoWay Biotechnology Company, North American). The sections were incubated with the HRP-conjugated secondary antibodies (Cat RS0002, Biotechnology Company, North American) and imaged with a fluorescence microscope. Briefly, the fresh paraffin sections would be gone through dewaxing, antigen repair, blocking, first and second antibody incubation, coloration and dewatering.

The pancreatic islets' cells apoptosis were detected by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay with the flesh tissue paraffin sections. Pancreas slides, made into 3.5μm paraffin sections after dehydration, were incubated with the TUNEL reaction mixture in a humidified chamber for 60 minutes at 37°C in light avoidance condition. Then, the sections were stained with DAPI at a concentration of 460 nm. The percentage of TUNEL-positive nuclei was used to access the apoptosis of the pancreatic islets' cells.

Western Blot Analysis {#S0002-S2005}
---------------------

The expression of liver tissue proteins, including PI3K, AKT and p-AKT were analyzed by Western blotting. Briefly, the total proteins of liver tissue were extracted with the RIPA buffer, and the concentrations were detected by using a Bradford Protein Assay Kit (Beyotime Biotechnology, Shanghai city, China). The protein was separated on 10% SDS-PAGE gels and then transferred onto nitrocellulose membranes. Then, the membranes were incubated in blocking solution for 2hours, and immersed with the primary antibodies for overnight at 4°C. Antibodies against PI3K (\#4292,100kDa, CST, USA), AKT (\#9272, 60kDa, CST, USA) and p-AKT (Ser473)(\#4060, 60kDa, CST, USA) were obtained from Cell Signaling Technology and used at a dilution of 1:1000; antibodies against GAPDH were used at a dilution of 1:1000. After that, the membranes were washed in TBST and incubated with appropriate horseradish peroxidase-conjugated secondary antibodies for 2hours. Finally, the protein bands were exposed to the chemiluminescent reagent (ECL) for about 3--10 minutes. All the proteins' expressions were obtained with fluorescence captured on X-ray photographic film in a dark room. The Image J software (NIH, Bethesda, MD, United States) was used for quantitative analysis the band densities of the above proteins.

Statistical Analysis {#S0002-S2006}
--------------------

The data of this study were expressed as mean±SD in each group. Statistical Product and Service Solutions (SPSS) statistics 22.0 and GraphPad Prism 8.0 software (San Diego, CA, United States) were applied for the data statistical analysis and graphics. Unpaired *t*-test was used to analyze statistical comparisons between two groups when necessary. Multiple comparisons were compared by one-way (or two-way) analysis of variance (ANOVA) followed by Bonferroni hoc tests. Statistically significant changes were classified as significant (\*) when *P*\<0.05.

Results {#S0003}
=======

Effects of HSYA on Body Weight, Fasting-Blood Glucose, and Glucose Tolerance in T2DM Rats {#S0003-S2001}
-----------------------------------------------------------------------------------------

The body weight ([[Supplementary Figure 1A](https://www.dovepress.com/get_supplementary_file.php?f=246381.doc)]{.ul}), the daily food and water consumption were monitored weekly. The rats' body weight in the Nor group was significantly higher than the Mod groups after STZ-modeling although there were no significant statistical differences between the other three groups (*P*\>0.05). The daily food and water consumption of the normal group were lower than the T2DM rats' groups after modeling. Expectantly, the daily food and water consumption of the HSYA group ([[Supplementary Figure 1B](https://www.dovepress.com/get_supplementary_file.php?f=246381.doc)]{.ul} and [[C](https://www.dovepress.com/get_supplementary_file.php?f=246381.doc)]{.ul}) were observably lower than Mod group and Met group after 4-week treatment, although no difference in the body weight.

We monitored the FBG weekly to evaluate the efficacy of HSYA in T2DM rats. The figure of FBG levels for modeling is shown in [Figure 2A](#F0002){ref-type="fig"}, the FBG of all the T2DM groups rats were ≧11.1 mmol/L after 6-week's modeling. The FBG of the Mod group was remarkably higher than the Nor group in the whole course of the experiment (*P*\<0.0001). The FBG significantly reduced in the Met and HSYA group after 2-week's treatment when compared to the Mod group (*P*\<0.001), and the best curative effect emerged at 8th week although the process fluctuates ([Figure 2B](#F0002){ref-type="fig"}). The glucose tolerance test, OGTT value and AUC-OGTT in the Met group (46.78) and HSYA group (58.73) were evidently lower than the Mod group (74.88)(*P*\<0.0001).Figure 2Effects of HSYA on fasting blood-glucose and glucose tolerance. (**A**) Fasting blood-glucose for modeling. (**B**) Fasting blood-glucose level. ^\#\#\#\#^*P\<*0.0001, vs Nor; \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001, vs Mod. (n=8 rats/group). (**C**) Oral glucose tolerance test (OGTT). (**D**) Area under curve (AUC) of OGTT. ^\#\#\#\#^*P\<*0.0001, vs Nor; \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001, vs Mod. Results are presented as means ± SD and n=8 in each group.

Effects of HSYA on Insulin Resistance and Pancreatic Islet Function {#S0003-S2002}
-------------------------------------------------------------------

As depicted in [Figure 3](#F0003){ref-type="fig"}, the levels of HOMA-IR and HOMA-βinT2DM rats were apparently higher than those in the Mod group. Although there was no statistical difference in the fasting insulin levels, the Mod group (14.06) still showed relatively high insulin resistance than the Met group (11.51) and HSYA group (13.47).Figure 3Effects of HSYA on the homeostasis model assessment of insulin resistance (HOMA-IR) and Homeostasis model assessment-β (HOMA-β). (**A**) Homeostasis model assessment of insulin resistance (HOMA-IR). (**B**) Homeostasis model assessment-β (HOMA-β). (**C**) Fasting insulin level. ^\#\#\#^*P\<*0.001, ^\#\#\#\#^*P\<*0.0001, vs Nor; \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, vs Mod. Results are presented as means ± SD and n=8 in each group.

Effects of HSYA on the Histopathological Change and the Insulin Expression in Pancreatic Tissues {#S0003-S2003}
------------------------------------------------------------------------------------------------

The hematoxylin-eosin (HE) stained sections of the pancreatic tissue are shown [Figure 4](#F0004){ref-type="fig"}. The T2DM rats indicated a decrease in acinar staining intensity that reflecting the defects in digestive function of the pancreas. Expectantly, remarkably differences in the number and pattern of the islets were appeared between the Mod group and the other three groups, as the islets with lots of vacuous areas in the Mod group. The immunohistochemical (IHC) staining results of insulin in pancreas tissues indicated that the Mod group rats' islet structure changed in both of the endocrine portion and exocrine (Acinus) portion when compared to the other three groups. The borders of the structures of the pancreas islets were distinctive from the exocrine glands due to the adequate zymogen granules; and the brown stained was shown the insulin expression in pancreas islets with immunohistochemical analysis. It suggested that HSYA and metformin might restore the impaired islets cells caused by the HFD and STZ in T2DM rats.Figure 4Effect of HSYA on the pathomorphism of pancreas tissues. Representative pictures of hematoxylin and Eosin (HE) staining (first row) (×100, n=6 each group) and insulin expression in pancreatic islets by immunohistochemistry (IHC) (second row) (×400, n=6 each group) of the tails of pancreas from each group rats after treatment. The red arrows indicate the pancreatic islets in the microscopic view (second row). The borders of the structures of the pancreas islets were distinctive from the exocrine glands due to the adequate zymogen granules; and the brown stained was shown the insulin expression in pancreas islets with immunohistochemical analysis.

Effect of HSYA on Apoptosis of Pancreatic β-Cells in T2DM Rats {#S0003-S2004}
--------------------------------------------------------------

In order to access the apoptosis of pancreatic β-cells in T2DM rats, TUNEL stain analysis was performed in this study. The TUNEL assay showed an observable increase in TUNEL-positive cells in the pancreatic islets in T2DM rats when compared to the Nor group ([Figure 5A](#F0005){ref-type="fig"} and [B](#F0005){ref-type="fig"}). In the Mod group, the TUNEL-positive (%) was markedly higher than the HSYA and Met groups; the HSYA-treatment group exhibited fewer numbers of TUNEL-positive cells.Figure 5Effect of HSYA on apoptosis of pancreatic β-cells in T2DM rats. Representative images of the TUNEL staining in the four groups. (**A**) (First column) DAPI staining (blue) indicates total nuclei (middle column) apoptotic nuclei detected by TUNEL staining (green), and (Last column) overlay of both types of staining. (**B**) The number of TUNEL-positive myocytes was performed as a percentage of total nuclei detected by DAPI staining (fluorescence microscopy, magnification, x60). ^\#\#\#\#^P\<0.0001, vs Nor; \*\*\*\*P\<0.0001, vs Mod. Results are presented as means ± SD and n=6 in each group.**Abbreviations:** Nor, Normal group; Mod, Model group; HSYA, hydroxysafflor yellow A.

Effects of HSYA on the Blood Lipids in T2DM Rats {#S0003-S2005}
------------------------------------------------

As shown in [Figure 6A--D](#F0006){ref-type="fig"}, the levels of the blood lipids including TC, TG and LDL-C in T2DM group rats were obviously higher than that in the Nor group. HSYA remarkably decreased the levels of TC, TG and LDL-C although there were no statistical differences between the Mod group and the other three groups.Figure 6Effects of HSYA on the blood lipid profiles in T2DM rats. (**A**) Triglycerides (TG) level; (**B**) Total cholesterol (TC) level; (**C**) Low-density lipoprotein cholesterol (LDL-C) level. (**D**) High-density lipoprotein cholesterol (HDL-C) level. The blood lipid profile was measured in each group after 8 weeks of treatment. Results are presented as means ± SD and n=8 in each group. ^\#\#^*P*\<0.01, ^\#\#\#\#^*P*\<0.0001, vs Nor; \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001, vs Mod.

Effects off HSYA on PI3K, AKT and p-AKT Expression and the Contents of Hepatic Glycogen and Glycogen Synthase in Liver {#S0003-S2006}
----------------------------------------------------------------------------------------------------------------------

To evaluate whether HSYA reduced the blood glucose and improves insulin resistance through PI3K/AKT pathway, the expressions of PI3K, AKT and p-AKT in liver were analysed by Western blot ([Figure 7A--D](#F0007){ref-type="fig"}). The expressions of PI3K, AKT and p-AKT levels were significantly depressed in T2DM rats when compared to the Nor group. The HSYA and metformin treatment groups evidently reversed the down-regulation of the above proteins' expression when compared to the Mod group. Meanwhile, the contents of hepatic glycogen and glycogen synthase in liver in the HSYA were distinctly higher than that of the Mod group ([Figure 7E](#F0007){ref-type="fig"} and [F](#F0007){ref-type="fig"}).Figure 7Effects of HSYA on PI3K, AKT and p-AKT expression and the content of hepatic glycogen and glycogen synthase in liver tissue. (**A, B**) The expression of PI3K in liver tissue. (**A, C**) The expression of AKT in liver tissue. (**A, D**) The expression of p-AKT in liver tissue. Results are presented as means ± SD and n=4 in each group. ^\#\#^*P\<*0.01, ^\#\#\#\#^*P\<*0.0001, vs Nor; \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001, vs Mod. (**E**) The level of hepatic glycogen in liver tissue. (**F**) The level of glycogen synthase in liver tissue. Results are presented as means ± SD and n=8 in each group. ^\#\#\#^*P\<*0.001, ^\#\#\#\#^*P\<*0.0001, vs Nor; \**P*\<0.05, \*\**P*\<0.01, \*\*\*\**P*\<0.0001, vs Mod.

Discussion {#S0004}
==========

The insulin resistance and the impaired insulin secretion were the major characteristic of T2DM, which associate with the high-fat diet, inflammation and other environmental factors. The T2DM rats' model, simulating the pathology of human T2DM, was critical to access the curative effect of the preclinical drugs for T2DM. The compositive method for T2DM modeling, conducting HFD for some weeks (4--8 w) followed by treating with a low dose of streptozotocin, which was evidenced to be a highly simulated human T2DM modeling method.[@CIT0013],[@CIT0018],[@CIT0019] In our study, given 4 weeks' HFD and a low dose of STZ (35 mg/kg) for T2DM modeling, as shown in the [Figures 2](#F0002){ref-type="fig"} and [3](#F0003){ref-type="fig"}, the levels of FBG, OGTT, HOAM-IR, HOMA-β and the pathological results of T2DM rats suggested that the T2DM rats were induced successfully. After 8-week treatment of HSYA, the results indicated that HSYA could lower FBG and increase the glucose tolerance level, improve insulin resistance and activated insulin signaling pathway.

The improving of insulin resistance and inhibit the apoptosis of pancreatic β-cells would be the major methods prevent and treat T2DM. In our study, HSYA-treatment reduced the HOMA-IR level at a rate of 42.06% and increased the HOMA-βlevel at a rate of 112% when compared to the Mod group. Feeding with HFD could induce hyperlipemia and insulin resistance,[@CIT0020],[@CIT0021] HSYA-treatment not only decreased FBG but had the anti-hyperlipidemic effect which would improve insulin resistance indirectly. Although HDL-C had the antioxidant and anti-inflammatory effects[@CIT0022] and some studies[@CIT0023],[@CIT0024] showed that the HDL-C level in T2DM rats would be higher than that of the normal rats, our founding suggested that there was no statistical difference between them as the previous study.[@CIT0025]

In this study, the T2DM rats indicated a decrease in acinar staining intensity that reflecting the defects in digestive function of the pancreas. The insulin granules and their intensity in β-cells were reduced in T2DM rats, and HSYA could reverse the impaired islets β-cells as shown in the Immunohistochemical results. As the previous studies described, HSYA could alleviate apoptosis and autophagy of neural stem cells[@CIT0026] and reduces apoptosis after I/R injury in kidney.[@CIT0027] There were numerous TUNEL-positive cells appeared in the islets of the Mod group, while HSYA-treatment exhibited fewer numbers of TUNEL-positive cells.

As the previous studies,[@CIT0028]--[@CIT0030] The PI3K/AKT signal pathway related to the glucose metabolism, which was critical for insulin aroused glucose intake in liver. The glycogen synthase kinase 3b (GSK3b) was one of the numerous downstream targets of Akt phosphorylates.[@CIT0031],[@CIT0032] Akt activation promoted the cells' survival by phosphorylation, and GSK3b inactivation of apoptosis-inducing factors.[@CIT0033] GSK3b is the key enzyme involved in hepatic glucose metabolism, which can decrease the synthesis of hepatic glycogen by phosphorylation of glycogen synthase (GS).[@CIT0034] In our study, the glycogen synthase level in liver was lower in the Mod group than that of Nor group, while HSYA-treatment could reverse the down-regulated GS. GS promoted the conversion of excess glucose into glycogen in the blood. HSYA could protect against cerebral ischemia-reperfusion injury by anti-apoptotic effect through increasing the expression of phosphorylations of Akt and GSK3b.[@CIT0011] HSYA reversed the down-regulated expression of PI3K, AKT and p-AKT levels in T2DM rats in this study.

Additionally, the sub-chronic toxicity of HSYA (180 mg/kg) with 90 days of intraperitoneal injections in rats showed that there is not an obvious pathological change in the organs in rats.[@CIT0035] Although HSYA has a poor oral bioavailability (1.2%),[@CIT0036] it was with high uptake and eliminated slowly in the rats with blood stasis syndrome.[@CIT0037] Moreover, HSYA might be a potential therapeutic drug for obesity by regulating the gut microbiota.[@CIT0038] Therefore, a higher dose of HSYA (120 mg/kg) was used for intervention in our study.

Conclusion {#S0005}
==========

In conclusion, our results suggested that HSYA could promote PI3K/Akt activation and inhibit the apoptosis of pancreatic β-cells directly or indirectly, which might be the underlying mechanisms in HSYA to improve insulin resistance and regulate glycolipid metabolism on HFD and STZ-induced T2DM rats.
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